Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Telaglenastat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Calithera Biosciences Reports Second Quarter 2022 Financial Results
    Calithera Biosciences Reports Second Quarter 2022 Financial Results

    15 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/15/2498526/32478/en/Calithera-Biosciences-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Highlights.html

    GLOBENEWSWIRE
    15 Aug 2022
    Share Share
    Struggling Calithera nabs 2 cheap cancer assets from Takeda
    Struggling Calithera nabs 2 cheap cancer assets from Takeda

    20 Oct 2021

    // THEPHARMALETTER

    https://www.thepharmaletter.com/article/two-new-drugs-add-harmony-to-calithera-s-precision-pipeline?__cf_chl_jschl_tk__=pmd_x66vxwinkDHJdlA02hF8AvCwosLXtWK1gLCV4NmksrM-1634712524-0-gqNtZGzNApCjcnBszQs9

    THEPHARMALETTER
    20 Oct 2021
    Share Share
    Slammed with PhII flop for lead drug, Calithera lays off a third of its staffers
    Slammed with PhII flop for lead drug, Calithera lays off a third of its staffers

    05 Jan 2021

    // Amber Tong ENDPTS

    https://endpts.com/slammed-with-phii-flop-for-lead-drug-calithera-lays-off-a-third-of-its-staffers/

    Amber Tong ENDPTS
    05 Jan 2021
    Share Share
    Calithera Announces Expansion of Ongoing Trial Evaluating Telaglenastat
    Calithera Announces Expansion of Ongoing Trial Evaluating Telaglenastat

    04 Nov 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/11/04/2120344/0/en/Calithera-Biosciences-Announces-Expansion-of-Ongoing-Clinical-Trial-Evaluating-Telaglenastat-in-Combination-with-palbociclib-IBRANCE.html

    GLOBENEWSWIRE
    04 Nov 2020
    Share Share
    Calithera Biosc's Completes Pt Enrollment in Ph 2 Telaglenastat + Everolimus
    Calithera Biosc's Completes Pt Enrollment in Ph 2 Telaglenastat + Everolimus

    06 Feb 2019

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2019/02/04/1709700/0/en/Calithera-Biosciences-Completes-Patient-Enrollment-in-Randomized-Phase-2-ENTRATA-Trial-of-Telaglenastat-CB-839-and-Everolimus-in-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    06 Feb 2019
    Share Share